• Abstract
• Full-Text PDF [511 KB]
• Full-Text XML
• Article Versions Notes
• Supplement File 1

• Article Statistics
• PubMed/Medline
• Google Scholar
• Order Reprints

• Cite this article
• Export to BibTeX
• Export to EndNote

• [+] on DOAJ
• Abbas, S
• Kelly, M
• Bowling, J
• Sims, J
• Waters, A
• Hamann, M
• [+] on Google Scholar
• Abbas, S
• Kelly, M
• Bowling, J
• Sims, J
• Waters, A
• Hamann, M
• [+] on PubMed
• Abbas, S
• Kelly, M
• Bowling, J
• Sims, J
• Waters, A
• Hamann, M

•  CiteULike
•  Facebook
•  Mendeley
•  Twitter

This article is

• freely available
• re-usable

Mar. Drugs 2011, 9(11), 2423-2437; doi:10.3390/md9112423

Review

Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites

Samuel Abbas ¹ , Michelle Kelly ² , John Bowling ¹ , James Sims ¹ , Amanda Waters ¹  and Mark Hamann ^1,*

¹ Department of Pharmacognosy, School of Pharmacy, University of Mississippi, MS 38677, USA ² National Centre for Aquatic Biodiversity and Biosecurity, National Institute of Water and Atmospheric Research Ltd., Auckland Central 1149, New Zealand

* Author to whom correspondence should be addressed.

Received: 22 September 2011; in revised form: 9 November 2011 / Accepted: 11 November 2011 / Published: 21 November 2011

(This article belongs to the Special Issue Bioactive Compounds from Marine Sponges)

Download PDF Full-Text [511 KB, uploaded 21 November 2011 10:11 CET]

Abstract: Porifera have long been a reservoir for the discovery of bioactive compounds and drug discovery. Most research in the area has focused on sponges from tropical and temperate waters, but more recently the focus has shifted to the less accessible colder waters of the Antarctic and, to a lesser extent, the Arctic. The Antarctic region in particular has been a more popular location for natural products discovery and has provided promising candidates for drug development. This article reviews groups of bioactive compounds that have been isolated and reported from the southern reaches of the Arctic Circle, surveys the known sponge diversity present in the Arctic waters, and details a recent sponge collection by our group in the Aleutian Islands, Alaska. The collection has yielded previously undescribed sponge species along with primary activity against opportunistic infectious diseases, malaria, and HCV. The discovery of new sponge species and bioactive crude extracts gives optimism for the isolation of new bioactive compounds from a relatively unexplored source.

Keywords: bioactive molecules; Porifera; sponges; Alaskan Arctic; Aleutian Islands

Supplementary Files

• Supplementary File 1:

  PDF-Document (PDF, 341 KB)

Article Statistics

Cite This Article